TruScreen Group Limited — Investor Relations & Filings

TruScreen Group Limited develops and manufactures a proprietary cervical cancer screening system that utilizes opto-electrical technology for the real-time detection of precancerous and cancerous tissue. The system employs a single-use sensor to measure tissue response to specific electrical and optical stimuli, processing the data through an integrated algorithm to provide an immediate objective result. By eliminating the requirement for laboratory processing, tissue sampling, and specialized pathology infrastructure, the technology facilitates point-of-care screening in diverse clinical environments. The device is designed to address the limitations of traditional cytology, offering a non-invasive, portable solution that enhances the efficiency of screening programs and improves patient access to diagnostic results.